Condensed Consolidated Statement of Operations and Comprehensive Loss - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenues		$ 30,983	$ 17,877	$ 58,140	$ 28,997
Cost of Revenues		11,697	5,570	21,511	10,980
Gross Profit		19,286	12,307	36,629	18,017
Operating expenses:
Research and development, net		4,781	2,400	7,745	5,128
Clinical operations		1,913	759	3,990	1,636
Sales and marketing		26,443	8,442	48,694	17,360
General and administrative		13,710	1,347	16,318	2,461
Total operating expenses		46,847	12,948	76,747	26,585
Operating loss		27,561	641	40,118	8,568
Financial expense (income), net		2,870	(1)	3,043	(31)
Loss before taxes on income		30,431	640	43,161	8,537
Taxes on income		10	6	18	9
Net loss		30,441	646	43,179	8,546
Other comprehensive income (loss)		0	0	0	0
Comprehensive loss		$ 30,441	$ 646	$ 43,179	$ 8,546
Net loss per share (1):
Basic and diluted net loss per share	[1]	$ 1.15	$ 0.05	$ 2.15	$ 0.64
Weighted average number of common shares used in computing basic and diluted net loss per share	[1]	26,362,369	13,367,502	20,097,094	13,334,965

[1] Prior period results have been adjusted to reflect the exchange of Old Talkspace’s common stock for Talkspace’s common stock at an exchange ratio of approximately 1.134140 in June 2021 as a result of the Business Combination. See Note 3, “Business Combination,” for further details.